Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
13.99
+0.20 (1.45%)
At close: Mar 4, 2026, 4:00 PM EST
14.26
+0.27 (1.93%)
After-hours: Mar 4, 2026, 6:02 PM EST
Fulgent Genetics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Fulgent Genetics stock have an average target of 28.33, with a low estimate of 25 and a high estimate of 30. The average target predicts an increase of 102.50% from the current stock price of 13.99.
Analyst Consensus: Buy
* Price targets were last updated on Nov 11, 2025.
Analyst Ratings
The average analyst rating for Fulgent Genetics stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $21 → $30 | Hold | Maintains | $21 → $30 | +114.44% | Nov 11, 2025 |
| UBS | UBS | Hold → Strong Buy Upgrades $20 → $30 | Hold → Strong Buy | Upgrades | $20 → $30 | +114.44% | Aug 5, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $23 → $21 | Hold | Maintains | $23 → $21 | +50.11% | Aug 4, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $16 → $23 | Hold | Maintains | $16 → $23 | +64.40% | May 6, 2025 |
| Raymond James | Raymond James | Buy Reiterates $24 → $25 | Buy | Reiterates | $24 → $25 | +78.70% | May 5, 2025 |
Financial Forecast
Revenue This Year
357.08M
from 322.67M
Increased by 10.66%
Revenue Next Year
400.55M
from 357.08M
Increased by 12.17%
EPS This Year
-0.33
from -1.97
EPS Next Year
-0.16
from -0.33
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 372.4M | 426.6M | |
| Avg | 357.1M | 400.6M | |
| Low | 339.0M | 373.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.4% | 19.5% | |
| Avg | 10.7% | 12.2% | |
| Low | 5.1% | 4.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.07 | -0.01 | |
| Avg | -0.33 | -0.16 | |
| Low | -0.59 | -0.41 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.